CBUSNasdaqAgricultural ChemicalsFiscal year ends December 31
Cibus, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.31−0.01 (-0.76%)
Close on Oct 19, 2026
- Market cap
- $100.55M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2014 to 2025
Gross margin
–
Operating margin
-2680.1%−2496.3 pts over 5 years
Net margin
-3492.3%−3304.3 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -14.6% | +185.1% | -31.3% | +11.1% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -64.7% | -90.2% | -223.0% | |
| Return on assets | – | -59.2% | -38.8% | |
| Current ratio | 1.91 | 5.70 | 0.72 | |
| Debt to equity | – | 0.04 | 0.02 | |
| Net debt to EBITDA | – | 0.40× | 0.10× | |
| Interest coverage | -2421.8× | -30.5× | – | |
| Inventory turnover | – | 17.7× | – | |
| Capex to revenue | 2612.5% | 7.5% | 15.9% | |
| Diluted shares | 0M | 1M | 46M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Cibus generated $193.02M from operations and spent $7.72M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$193.02M
Used
$7.72M
Capital expenditure$7.72M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-3492.3%
×Asset turnover0.01×
×Equity multiplier5.75×
=Return on equity, FY2025-223.0%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -3492.3% | 0.01× | 5.75× | -223.0% |
| FY2024 | -5898.4% | 0.01× | 2.32× | -130.4% |
| FY2023 | -14729.1% | 0.01× | 1.89× | -178.0% |
| FY2022 | -10758.6% | 0.01× | 2.79× | -158.1% |
| FY2021 | -112.4% | 0.52× | 1.97× | -114.5% |
| FY2020 | -188.0% | 0.32× | 1.52× | -90.2% |
| FY2019 | -542.9% | 0.07× | 1.33× | -50.8% |
| FY2018 | -11820.8% | 0.00× | 1.27× | -37.0% |
| FY2017 | -5114.2% | 0.01× | 1.26× | -73.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$127.09M
- Cash generatingOperating cash flow above zero-$50.59M
- Return on assets improvedROA up on the prior year-46.2% → -36.3%
- Earnings backed by cashOperating cash flow above net income-$50.59M vs -$127.09M
- Less leverageLong-term debt to assets fell0.1% → 0.0%
- Better liquidityCurrent ratio rose0.85 → 0.72
- No dilutionShare count did not rise23M → 46M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.01 → 0.01